Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ge Shen

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Frontiers in Immunology|November 10, 2022
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis BSi Xie, Liu Yang, Xiaoyue Bi, et al.
Frontiers in Immunology|February 16, 2023
Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapyXiaoyue Bi, Si Xie, Shuling Wu, et al.
Journal of Viral Hepatitis|August 6, 2019
Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levelsYao Xie, Wei Yi, Lu Zhang, et al.
Biomedical and Environmental Sciences : BES|April 16, 2025
Comprehensive Analysis of Oncogenic, Prognostic, and Immunological Roles of FANCD2 in Hepatocellular Carcinoma: A Potential Predictor for Survival and ImmunotherapyMeng Jiao Xu, Wen Deng, Ting Ting Jiang, et al.
Frontiers in Immunology|December 8, 2022
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapyWeihua Cao, Huihui Lu, Luxue Zhang, et al.
Journal of Viral Hepatitis|August 6, 2019
Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapyMing-Hui Li, Wei Yi, Lu Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 4, 2014
[Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]Ge Shen, Lu Zhang, Yan-Li Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 21, 2014
[Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, et al.
Frontiers in Immunology|February 10, 2023
Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatmentYanjie Lin, Ge Shen, Si Xie, et al.
Frontiers in Immunology|January 23, 2023
Postpartum hepatitis and host immunity in pregnant women with chronic HBV infectionLu Zhang, Tingting Jiang, Ying Yang, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Frontiers in Immunology|November 10, 2022
Cytokine profiles and CD8+ T cells in the occurrence of acute and chronic hepatitis BSi Xie, Liu Yang, Xiaoyue Bi, et al.
Frontiers in Immunology|February 16, 2023
Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapyXiaoyue Bi, Si Xie, Shuling Wu, et al.
Journal of Viral Hepatitis|August 6, 2019
Evaluation of a logistic regression model for predicting liver necroinflammation in hepatitis B e antigen-negative chronic hepatitis B patients with normal and minimally increased alanine aminotransferase levelsYao Xie, Wei Yi, Lu Zhang, et al.
Biomedical and Environmental Sciences : BES|April 16, 2025
Comprehensive Analysis of Oncogenic, Prognostic, and Immunological Roles of FANCD2 in Hepatocellular Carcinoma: A Potential Predictor for Survival and ImmunotherapyMeng Jiao Xu, Wen Deng, Ting Ting Jiang, et al.
Frontiers in Immunology|December 8, 2022
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapyWeihua Cao, Huihui Lu, Luxue Zhang, et al.
Journal of Viral Hepatitis|August 6, 2019
Predictors of sustained functional cure in hepatitis B envelope antigen-negative patients achieving hepatitis B surface antigen seroclearance with interferon-alpha-based therapyMing-Hui Li, Wei Yi, Lu Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 4, 2014
[Study on the etiology of acute hepatitis hospitalized patients in Beijing Ditan Hospital from 2002 to 2011]Ge Shen, Lu Zhang, Yan-Li Zhang, et al.
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|March 21, 2014
[Analyse related factors of impact and prognosis of 73 cases of severe hepatitis]Jun-Mei Zhao, Lu Zhang, Qing-Wei Du, et al.
Frontiers in Immunology|February 10, 2023
Dynamic changes of the proportion of HLA-DR and CD38 coexpression subsets on T lymphocytes during IFN-based chronic hepatitis B treatmentYanjie Lin, Ge Shen, Si Xie, et al.
Frontiers in Immunology|January 23, 2023
Postpartum hepatitis and host immunity in pregnant women with chronic HBV infectionLu Zhang, Tingting Jiang, Ying Yang, et al.
Pageof 12